Qualifying R&D Expenditure in the UAE: Which Costs Count?

What counts as qualifying R&D expenditure in the UAE?

Qualifying R&D expenditure in the UAE is restricted to four exhaustive categories: staff costs, consumable costs, subcontracting fees and contributions made under a Cost Contribution Arrangement. A cost that does not fall inside one of those four categories cannot enter the claim, no matter how directly it supports the research. That is the single most important framing point, and it is where most first-time schedules go wrong.

The categories sit on top of a separate qualifying-activity test. Expenditure only counts if it was incurred on activity that itself qualifies as R&D — systematic, investigative or experimental work directed at resolving scientific or technological uncertainty, performed in the UAE. Passing the activity test does not make every associated cost claimable, and incurring a cost in one of the four categories does not make the underlying activity qualifying. Both tests have to hold at once.

The incentive itself is an expenditure-based refundable tax credit sitting inside the Corporate Tax regime under Federal Decree-Law No. 47 of 2022. It was announced by the Ministry of Finance as applying to tax periods starting on or after 1 January 2026 [VERIFY], with a pre-approval step before the credit is taken in the Corporate Tax return. Because the credit is a percentage of the qualifying base, every dirham correctly captured in the schedule is worth a fixed multiple of itself — and every dirham incorrectly included is a direct assessment risk.

Which staff costs qualify — and how does the 30% uplift work?

Staff costs are the largest qualifying category for almost every claimant, and the only one that carries an automatic uplift. They cover amounts incurred in respect of full-time, full-time-equivalent or externally provided workers who are directly and actively engaged in qualifying R&D and located in the UAE while performing it. Physical location matters: an engineer working the same project from an overseas office contributes nothing to the qualifying base.

The concept used is total employment cost, not basic salary. Housing and transport allowances, medical insurance, pension contributions to GPSSA or ADPF, end-of-service gratuity, bonuses, benefits in kind and R&D-related training all fall inside the category, as does the cost of a secondee where the claiming entity bears it. Getting the base right matters more than most claimants expect — for a typical UAE package, allowances and end-of-service can add 30–45% to basic salary before any uplift is applied.

On top of that base, the reported design applies an automatic 30% uplift [VERIFY] to represent overheads reasonably attributable to R&D. It is not optional and it does not require you to identify, allocate or evidence a single specific overhead cost. It simply increases the qualifying base by 30% before the credit rate is applied.

How do you treat employees who only spend part of their time on R&D?

Where an employee is not engaged in qualifying R&D on a full-time basis, only the portion of employment cost reasonably attributable to the R&D time qualifies — and that apportioned amount is then uplifted. The apportionment has to be supported by contemporaneous evidence, which in practice means timesheets or an activity log maintained as the work happens rather than reconstructed at year end.

Take a software engineer on a total employment cost of AED 480,000 a year who spends 60% of their time on qualifying R&D and 40% on commercial feature development. The qualifying staff cost is AED 288,000, which after the 30% uplift becomes AED 374,400 of qualifying expenditure. The remaining AED 192,000 of employment cost stays out of the claim entirely.

The weakness in most claims is not the arithmetic but the evidence behind the 60%. A percentage asserted in a spreadsheet, with no underlying record of who did what and when, is the first thing a reviewer will test. Our payroll services team configures time capture at the point of payroll processing so the allocation exists as a by-product of normal operations, and our accounting and bookkeeping team reconciles it to the ledger each month.

Which consumable costs qualify for the R&D tax credit?

Consumable costs are amounts incurred on consumable or transformable materials directly used in performing qualifying R&D that are no longer usable in their original form afterwards. The test is consumption or transformation. If the item survives the process intact and can be used again, it is not a consumable.

Inside the category: raw materials and reagents, water, fuel and power attributable to the R&D process, licence fees and similar costs relating to intangible assets that are not capital in nature, and payments to patients or subjects participating in clinical trials forming part of the qualifying activity. Where a material is only partly used in R&D, the attributable portion qualifies on the same apportionment logic that applies to staff time.

Outside the category: consumables disposed of in the ordinary course of business for consideration — that is, materials that end up in something you sell — and any consumable acquired from another member of the same Tax Group. The first exclusion is the one that catches manufacturers. Materials consumed producing prototypes that are subsequently sold to customers fall out of the claim even though the development work itself was genuine R&D.

Why is equipment and capital expenditure excluded?

Capital expenditure does not appear in any of the four qualifying categories, so the acquisition cost of laboratory equipment, computer hardware, machinery, scientific instruments or facilities is simply not qualifying R&D expenditure. This is a structural feature of the design, not an oversight, and it catches capital-intensive claimants hard.

The distinction is between the process and the thing performing the process. A spectrometer used across dozens of experiments is excluded; the reagents it analyses are included. A server cluster is excluded; the metered power drawn by an R&D compute workload is arguable as a consumable. Depreciation on excluded assets does not rescue the position either — depreciation is not one of the four categories.

The practical consequence is that the credit favours people-heavy R&D over asset-heavy R&D. A software or formulation team spending most of its budget on salaries will convert a large share of total project cost into qualifying expenditure. A hardware or process-engineering team spending heavily on capital plant will convert far less. That asymmetry is worth modelling before you build the R&D budget, not after.

When do subcontracting fees count as qualifying R&D expenditure?

Fees paid to a third party performing qualifying R&D can be included, but only where all six conditions are satisfied at once [VERIFY]. Failing any one of them removes the whole fee from the claim — there is no partial credit for a subcontract that meets five of six.

1. UAE-based counterparty — the activities are contracted out to a person based in the UAE.
2. UAE-performed — the activities are actually undertaken within the UAE, not merely contracted from it.
3. Not back-to-back inbound — the activities were not themselves subcontracted to the claimant by another party.
4. No onward subcontracting — the subcontractor does not pass the activities on to a further party.
5. No Foreign PE attribution — the expenditure is not attributable to a Foreign Permanent Establishment.
6. Audited financials for related parties — where claimant and subcontractor are Related Parties, the subcontractor maintains audited financial statements.

Two of these deserve particular attention. The no-onward-subcontracting condition means you need visibility into your supplier’s own supply chain, because a UAE laboratory that quietly routes part of the work to an overseas affiliate takes the whole fee out of your claim. And the related-party audit condition creates a real compliance obligation on a company that may never previously have needed audited statements. As an MoE-approved auditor, Fastlane prepares those statements alongside the claim — see our audit services.

Related-party subcontracting also has to be priced at arm’s length under Article 34 of the Corporate Tax Law. Where the group crosses the documentation thresholds in Ministerial Decision No. 97 of 2023 — own revenue of AED 200 million, or consolidated group revenue of AED 3.15 billion — a Master File and Local File are required, and the R&D subcontract will be one of the transactions tested. Our transfer pricing team handles that documentation.

How are Cost Contribution Arrangements treated?

A Cost Contribution Arrangement is a contractual arrangement among parties to share the contributions and risks of joint R&D where the activity is expected to create benefits for each participant’s own business. Where a UAE entity participates in a CCA, its contributed share of qualifying R&D expenditure can qualify, provided two conditions are met [VERIFY]: the contribution is determined in accordance with the arm’s length principle, and it corresponds to the participant’s expected share of the benefits arising.

Where the CCA activity is conducted partly inside and partly outside the UAE, only the portion attributable to UAE-based activity is qualifying expenditure. That split needs to be evidenced on the same basis as any other apportionment — a defensible allocation key, applied consistently, documented at the time.

CCAs are the most documentation-intensive of the four categories because the arm’s length determination of each participant’s contribution is a transfer pricing question before it is an R&D question. In practice a benefit-expectation analysis, a contribution valuation and a written arrangement all need to exist before the period end, not after it. Treat the CCA route as a planned structure rather than something you can characterise retrospectively.

Which Tax Group costs are excluded from an R&D claim?

Three intra-group exclusions cut across the categories, and together they are the single biggest structural trap for groups. Staff costs recharged to the claimant from another Tax Group member are excluded, even where the underlying activity is genuine R&D. Consumables and licences acquired from a Tax Group member are excluded. Subcontracting between Tax Group members is excluded.

The practical effect is that a common and otherwise sensible structure — a group service company that employs the technical staff and recharges them to operating entities — produces a qualifying base of close to zero at the claimant level. The costs are real, the activity qualifies, and none of it counts, because the cost reaches the claimant as an intra-group recharge rather than as its own employment cost.

Fixing this is a structuring exercise that has to happen before the costs are incurred. Options generally involve employing the R&D team directly in the entity that will claim, or revisiting whether the entities should sit in the same Tax Group at all — a decision with consequences well beyond the R&D credit. Model it against the wider group position using our UAE corporate tax calculator and the corporate tax guide for UAE businesses before you move anything.

Worked example: how do the four categories add up?

Take a UAE-based biotechnology company running a novel drug formulation project through a full tax year. It employs ten R&D scientists, consumes reagents, pays clinical trial subjects and uses an independent UAE laboratory for one workstream. Here is how the qualifying expenditure builds.

Two points about what this schedule does not show. First, the credit itself: the reported design applies tiered credit rates that vary with revenue and average R&D headcount [VERIFY — rates and bands are unconfirmed; the Ministry of Finance announcement referred to a refundable credit in the 30–50% range]. Do not compute an expected credit from a rate you have not confirmed against the published decision. Second, the excluded costs: had the same company bought a AED 900,000 analyser for the project, none of it would appear above.

Notice also how the composition drives the outcome. Staff costs plus uplift account for AED 1,950,000 of the AED 2,730,000 base — 71%. Any weakness in payroll allocation therefore damages the claim far more than an error in consumables ever could, which is why the time-capture discipline described above matters more than any other single control.

How do you build a qualifying R&D expenditure schedule?

A defensible schedule is built in five steps, and the order matters — each step narrows the population the next one works on. Budget two to three weeks for a first-time schedule covering a single project, and considerably longer where the group has intra-group cost flows to unpick.

1. Define the project boundary — fix the start and end of each qualifying R&D project. Costs incurred before the technological uncertainty arose, or after it was resolved, sit outside the boundary and outside the schedule.
2. Extract and apportion staff costs — pull total employment cost per employee from payroll, apply the documented R&D time percentage, then apply the 30% uplift. Check every individual is UAE-located and under your direct supervision and control.
3. Isolate consumables — separate consumed or transformed materials from capital purchases, from group-sourced items, and from anything that ends up in output sold in the ordinary course of business.
4. Test each subcontract and CCA contribution — run every subcontract through all six conditions and every CCA contribution through both. Obtain audited financial statements for related-party subcontractors before period end, not after.
5. Reconcile, document and file — tie the schedule back to the trial balance, document every apportionment key, complete the pre-approval step, then carry the figure into the Corporate Tax return.

The reconciliation in step five is what separates a schedule from a spreadsheet. If the total cannot be traced back into audited or ledger figures, the entire claim rests on an assertion. That is also the step most often skipped when a claim is assembled in the final fortnight before a filing deadline.

What records are required, and what is the exposure if you get it wrong?

Records supporting a Corporate Tax return must be retained for seven years after the end of the relevant tax period under Federal Decree-Law No. 47 of 2022. For an R&D claim that means timesheets and activity logs, payroll records showing total employment cost, purchase and consumption records for materials, executed subcontracts, audited statements for related-party subcontractors, CCA documentation and the reconciled expenditure schedule itself.

Corporate Tax penalties are governed by Cabinet Decision No. 75 of 2023 as amended by Cabinet Decision No. 10 of 2024 — a separate authority from the VAT and Excise penalty regime in Cabinet Decision No. 129 of 2025, and the two must never be conflated. Beyond the fixed penalties, the real exposure on an overstated claim is repayment of the credit plus the consequences of an incorrect return.